Literature DB >> 34641715

The Influence of Emotions on Treatment Decisions About Low-Risk Thyroid Cancer: A Qualitative Study.

Susan C Pitt1, Megan C Saucke1, Benjamin R Roman2, Stewart C Alexander3, Corrine I Voils1,4.   

Abstract

Background: Little is known about the role of emotions in treatment decisions for thyroid cancer. We aimed to characterize the emotional content of patient-surgeon communication during decision-making about low-risk thyroid cancer treatment.
Methods: We audio-recorded conversations about treatment for clinically low-risk thyroid cancer or biopsy suspicious for thyroid cancer between patients (n = 30) and surgeons (n = 9) in two diverse, academic hospitals in the United States. Inductive and deductive content analyses were used to characterize the emotional content in verbatim transcripts.
Results: Patients' expression of emotion focused on primarily on their diagnosis and treatment outcomes. Patients commonly expressed negative emotions like fear and anxiety about "the C-word" and worried about the cancer growing or spreading. In response, most surgeons used education, as opposed to empathy or validation, to reassure patients, often highlighting low probabilities of adverse events. Surgeons emphasized the "slow-growing" nature and excellent prognosis of thyroid cancer compared with other malignancies. When discussing treatment options, surgeons often described alternatives in terms of their emotional outcomes. Some described total thyroidectomy as providing "peace of mind" or a "sense of completeness," warning that cancer or thyroid tissue remaining in the body with active surveillance or lobectomy might "worry" or "bother" patients. Surgeons supported deliberation by reassuring patients that there are "two right answers" and "no rush" to decide. Conclusions: Patients express negative emotions during treatment decision-making. In response, surgeons often miss opportunities to provide empathy in addition to education. Surgeons and patients both acknowledge patient fear and anxiety as a reason to choose thyroidectomy instead of active surveillance. Peace of mind gained by patients and surgeons as a result of thyroidectomy may lead to overtreatment of patients with low-risk thyroid cancer.

Entities:  

Keywords:  decision; emotion; low-risk; overtreatment; thyroid cancer

Mesh:

Year:  2021        PMID: 34641715      PMCID: PMC8721509          DOI: 10.1089/thy.2021.0323

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  40 in total

1.  Worry in Thyroid Cancer Survivors with a Favorable Prognosis.

Authors:  Maria Papaleontiou; David Reyes-Gastelum; Brittany L Gay; Kevin C Ward; Ann S Hamilton; Sarah T Hawley; Megan R Haymart
Journal:  Thyroid       Date:  2019-07-25       Impact factor: 6.568

2.  Contralateral prophylactic mastectomy for breast cancer: addressing peace of mind.

Authors:  Steven J Katz; Monica Morrow
Journal:  JAMA       Date:  2013-08-28       Impact factor: 56.272

Review 3.  A Systematic Review of Unmet Information and Psychosocial Support Needs of Adults Diagnosed with Thyroid Cancer.

Authors:  Yong Gyu Hyun; Ahmad Alhashemi; Rouhi Fazelzad; Alyse S Goldberg; David P Goldstein; Anna M Sawka
Journal:  Thyroid       Date:  2016-08-02       Impact factor: 6.568

Review 4.  Cognitive biases and heuristics in medical decision making: a critical review using a systematic search strategy.

Authors:  J S Blumenthal-Barby; Heather Krieger
Journal:  Med Decis Making       Date:  2014-08-21       Impact factor: 2.583

5.  Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years.

Authors:  Mohamed Abdelgadir Adam; John Pura; Paolo Goffredo; Michaela A Dinan; Terry Hyslop; Shelby D Reed; Randall P Scheri; Sanziana A Roman; Julie A Sosa
Journal:  J Clin Endocrinol Metab       Date:  2015-01       Impact factor: 5.958

6.  The power of clinicians' affective communication: how reassurance about non-abandonment can reduce patients' physiological arousal and increase information recall in bad news consultations. An experimental study using analogue patients.

Authors:  Milou S C Sep; Mara van Osch; Liesbeth M van Vliet; Ellen M A Smets; Jozien M Bensing
Journal:  Patient Educ Couns       Date:  2014-01-13

7.  Support needs and survivorship concerns of thyroid cancer patients.

Authors:  Stephanie Morley; Melanie Goldfarb
Journal:  Thyroid       Date:  2015-04-28       Impact factor: 6.568

8.  'It's not like you just had a heart attack': decision-making about active surveillance by men with localized prostate cancer.

Authors:  Robert J Volk; Stephanie L McFall; Scott B Cantor; Theresa L Byrd; Yen-Chi L Le; Deborah A Kuban; Patricia Dolan Mullen
Journal:  Psychooncology       Date:  2013-11-14       Impact factor: 3.894

9.  Differences in long-term quality of life between hemithyroidectomy and total thyroidectomy in patients treated for low-risk differentiated thyroid carcinoma.

Authors:  Pim J Bongers; Caylee A Greenberg; Ralph Hsiao; Marloes Vermeer; Menno R Vriens; Martijn F Lutke Holzik; David P Goldstein; Karen Devon; Lorne E Rotstein; Anna M Sawka; Jesse D Pasternak
Journal:  Surgery       Date:  2019-10-15       Impact factor: 3.982

10.  Patient Perspectives on Treatment Options for Older Women With Hormone Receptor-Positive Breast Cancer: A Qualitative Study.

Authors:  Ton Wang; Nicole Mott; Jacquelyn Miller; Nicholas L Berlin; Sarah Hawley; Reshma Jagsi; Lesly A Dossett
Journal:  JAMA Netw Open       Date:  2020-09-01
View more
  2 in total

Review 1.  [Hemithyroidectomy or total thyroidectomy for low-risk papillary thyroid cancer? : Surgical criteria for primary and secondary choice of treatment in an interdisciplinary treatment concept].

Authors:  H Dralle; F Weber; A Machens; T Brandenburg; K W Schmid; D Führer-Sakel
Journal:  Chirurgie (Heidelb)       Date:  2022-09-19

2.  Trends in the Management of Localized Papillary Thyroid Carcinoma in the United States (2000-2018).

Authors:  Elisa Pasqual; Julie Ann Sosa; Yingxi Chen; Sara J Schonfeld; Amy Berrington de González; Cari M Kitahara
Journal:  Thyroid       Date:  2022-03-15       Impact factor: 6.506

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.